Biolife Solutions Inc (NASDAQ: BLFS) has reported E.P.S. of $-0.22 for its first fiscal quarter (ending March 31) versus $-0.32 for the same period a year ago. Relative to the consensus estimate of $-0.06, this was a shortfall of $-0.16. For the latest four quarters through March 31, E.P.S. were $-1.42 compared to $-3.43 a year ago.
Recent Price Action
Biolife Solutions Inc (NASDAQ: BLFS) stock rose modestly by 0.4% on 5/9/24. The stock closed at $18.01. Moreover, trading volume in this advance was above average at 124% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 3.0% during the last week.
Current PriceTarget Research Rating
BLFS’ future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Biolife Solutions has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Biolife Solutions has a poor Appreciation Score of 17 but a very high Power Rating of 92, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment